Mayer, Robert J.
Hochster, Howard S.
Cohen, Steven J.
Winkler, Robert
Makris, Lukas
Grothey, Axel
Clinical trials referenced in this document:
Documents that mention this clinical trial
Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer
https://doi.org/10.1007/s00280-018-3686-5
Funding for this research was provided by:
Taiho Oncology, Inc.
Article History
Received: 10 August 2018
Accepted: 5 September 2018
First Online: 22 October 2018
Compliance with ethical standards
:
: Robert J. Mayer has received honoraria from Taiho and consulting fees from Taiho and CASI Pharmaceuticals. Howard S. Hochster has received consulting fees from Bayer, Genentech, Amgen, and Merck. Steven J. Cohen has received consulting fees from Taiho, Bayer HealthCare Pharmaceuticals, Celgene, and Merrimack. Robert Winkler is employed by Taiho and has received leadership compensation and travel and accommodation support from Taiho. Lukas Makris is employed by Stathmi Inc. and is a statistical consultant for Taiho. Axel Grothey is employed by Mayo Clinic Cancer Center; Mayo Clinic Foundation has received consulting honoraria from Taiho and Bayer from his work.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.